Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus lifestyle counselling for adipose tissue distribution and metabolic function in obesity with early dysglycemia
2013-001356-36Phase 2Completed
- Sponsor
- "G. d'Annunzio" University
- Start
- Jun 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of liraglutide in obesity, prediabetes, impaired fasting glucose (IFG) and 1 more (2 arms), sponsored by "G. d'Annunzio" University. Primary endpoint: Change in subcutaneous and visceral fat distribution. Started Jun 2013; status: completed.
02
Drugs
03
Conditions
obesityprediabetesimpaired fasting glucose (IFG)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-001356-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001356-36.